Proteomic analysis of membrane-associated proteins from rat liver autophagosomes

Autophagy

Volumn 3, Issue 4, 2007, Pages 300-322

  Øverbye, Anders ^a   Fengsrud, Monica ^a   Seglen, Per O ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Autophagy; Hepatocyte; Membrane protein; Proteomics

Indexed keywords

ADENOSINE KINASE; AROMATIC HYDROCARBON; BETAINE; CATECHOL METHYLTRANSFERASE; CHAPERONIN; DRUG METABOLIZING ENZYME; ENZYME VARIANT; FRUCTOSE BISPHOSPHATASE; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN 70; HOMOCYSTEINE METHYLTRANSFERASE; INORGANIC PYROPHOSPHATASE; MEMBRANE PROTEIN; METHIONINE ADENOSYLTRANSFERASE; METHYLTRANSFERASE; PEROXIREDOXIN; PEROXIREDOXIN 2; PEROXIREDOXIN 6; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; SELENIUM BINDING PROTEIN; SELENIUM BINDING PROTEIN 2; STEROID REDUCTASE; SULFOTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CELL MEMBRANE; CONJUGATION; CYTOSOL; DEMETHYLATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IMMUNOBLOTTING; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METHYLATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOSOME; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DENATURATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; PROTEOMICS; SILVER STAINING; TWO DIMENSIONAL GEL ELECTROPHORESIS;

RATTUS;

EID: 34250828455     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.3910     Document Type: Article

References (243)

1. Mortimore GE, Schworer CM. Induction of autophagy by amino-acid deprivation in perfused rat liver. Nature 1977; 270:174-6.
2. Fengsrud M, Lunde Sneve M, Øverbye A, Seglen PO. Structural aspects of mammalian autophagy. In: Klionsky DJ, ed. Autophagy. Georgetown, USA: Landes Bioscience, 2004:11-25.
3. Luiken JJFP, Van den Berg M, Heikoop JC, Meijer AJ. Autophagic degradation of peroxisomes in isolated rat hepatocytes. FEBS Lett 1992; 304:93-7.
4. Tuttle DL, Lewin AS, Dunn WA. Selective autophagy of peroxisomes in methylotrophic yeasts. Eur J Cell Biol 1993; 60:283-90.
5. Rubinsztein DC, DiFiglia M, Heintz N, Nixon RA, Qin ZH, Ravikumar B, Stefanis L, Tolkovsky A. Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy 2005; 1:11-22.
6. Kirkegaard K, Taylor MP, Jackson WT. Cellular autophagy: Surrender, avoidance and subversion by microorganisms. Nat Rev Microbiol 2004; 2:301-14.
7. Deretic V. Autophagy in innate and adaptive immunity. Trends Immunol 2005; 26:523-8.
8. Rusten TE, Lindmo K, Juhász G, Sass M, Seglen PO, Brech A, Stenmark H. Programmed autophagy in the Drosophila fat body is induced by ecdysone treatment through regulation of the PI3K pathway. Dev Cell 2004; 7:179-92.
9. Levine B, Klionsky DJ. Development by self-digestion: Molecular mechanisms and biological functions of autophagy. Dev Cell 2004; 6:463-77.
10. Kisen GØ, Tessitore L, Costelli P, Gordon PB, Schwarze PE, Baccino FM, Seglen PO. Reduced autophagic activity in primary rat hepatocellular carcinoma and ascites rat hepatoma cells. Carcinogenesis 1993; 14:2501-5.
11. Edinger AL, Thompson CB. Defective autophagy leads to cancer. Cancer Cell 2003; 4:422-4.
12. Schwarze PE, Seglen PO. Reduced autophagic activity, improved protein balance and enhanced in vitro survival of hepatocytes isolated from carcinogen-treated rats. Exp Cell Res 1985; 157:15-28.
13. Levine B, Yuan J. Autophagy in cell death: An innocent convict? J Clin Invest 2005; 115:2679-88.
14. Klionsky DJ, Cregg JM, Dunn Jr WA, Emr SD, Sakai Y, Sandoval IV, Sibirny A, Subramani S, Thumm M, Veenhuis M, Ohsumi Y. A unified nomenclature for yeast autophagy-related genes. Dev Cell 2003; 5:539-45.
15. Mizushima N, Ohsumi Y, Yoshimori T. Autophagosome formation in mammalian cells. Cell Struct Funct 2002; 27:421-9.
16. Klionsky DJ. The molecular machinery of autophagy: Unanswered questions. J Cell Sci 2005; 118:1-18.
17. Seglen PO. Regulation of autophagic protein degradation in isolated liver cells. In: Glaumann H, Ballard FJ, eds. Lysosomes: Their Role in Protein Breakdown. London: Academic Press, 1987:369-414.
18. Suzuki K, Kirisako T, Kamada Y, Mizushima N, Noda T, Ohsumi Y. The pre-autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation. EMBO J 2001; 20:5971-81.
19. Kim J, Huang WP, Stromhaug PE, Klionsky DJ. Convergence of multiple autophagy and cytoplasm to vacuole targeting components to a perivacuolar membrane compartment prior to de novo vesicle formation. J Biol Chem 2002; 277:763-73.
20. Takeshige K, Baba M, Tsuboi S, Noda T, Ohsumi Y. Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction. J Cell Biol 1992; 119:301-11.
21. Natarajan K, Meyer MR, Jackson BM, Slade D, Roberts C, Hinnebusch AG, Marton MJ. Transcriptional profiling shows that Gcn4p is a master regulator of gene expression during amino acid starvation in yeast. Mol Cell Biol 2001; 21:4347-68.
22. Tallóczy Z, Jiang WX, Virgin HW, Leib DA, Scheuner D, Kaufman RJ, Eskelinen EL, Levine B. Regulation of starvation- and virus-induced autophagy by the eIF2α kinase signaling pathway. Proc Natl Acad Sci USA 2002; 99:190-5.
23. Abeliovich H, Dunn WA, Kim J, Klionsky DJ. Dissection of autophagosome biogenesis into distinct nucleation and expansion steps. J Cell Biol 2000; 151:1025-33.
24. Kovács AL, Seglen PO. Inhibition of hepatocytic protein degradation by methylaminopurines and inhibitors of protein synthesis. Biochim Biophys Acta 1981; 676:213-20.
25. Lawrence BP, Brown WJ. Inhibition of protein synthesis separates autophagic sequestration from the delivery of lysosomal enzymes. J Cell Sci 1993; 105:473-80.
26. Kabeya Y, Mizushima N, Yamamoto A, Oshitani-Okamoto S, Ohsumi Y, Yoshimori T. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci 2004; 117:2805-12.
27. Sou YS, Tanida I, Komatsu M, Ueno T, Kominami E. Phosphatidylserine in addition to phosphatidylethanolamine is an in vitro target of the mammalian Atg8 modifiers, LC3, GABARAP and GATE-16. J Biol Chem 2005; 281:3017-24.
28. Tanida I, Ueno T, Kominami E. LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 2004; 36:2503-18.
29. Hemelaar J, Lelyveld VS, Kessler BM, Ploegh HL. A single protease, Apg4B, is specific for the autophagy-related ubiquitin-like proteins GATE-16, MAP1-LC3, GABARAP, and Apg8L. J Biol Chem 2003; 278:51841-50.
30. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402:672-6.
31. Kihara A, Kabeya Y, Ohsumi Y, Yoshimori T. Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep 2001; 2:330-5.
32. Seglen PO, Gordon PB. 3-Methyladenine: A specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci USA 1982; 79:1889-92.
33. Petiot A, Ogier-Denis E, Blommaart EFC, Meijer AJ, Codogno P. Distinct classes of phosphatidyl inositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem 2000; 275:992-8.
34. Holen I, Gordon PB, Seglen PO. Protein kinase-dependent effects of okadaic acid on hepatocytic autophagy and cytoskeletal integrity. Biochem J 1992; 284:633-6.
35. Møller MTN, Samari HR, Holden L, Seglen PO. Regulation of mammalian autophagy by protein phosphorylation. In: Klionsky DJ, ed. Autophagy. Georgetown, USA: Landes Bioscience, 2004:48-58.
36. Codogno P, Meijer AJ. Signaling pathways in mammalian autophagy. In: Klionsky DJ, ed. Autophagy, Georgetown, USA: Landes Bioscience, 2004:26-47.
37. Inbal B, Bialik S, Sabanay I, Shani G, Kimchi A. DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J Cell Biol 2002; 157:455-68.
38. Strømhaug PE, Berg TO, Fengsrud M, Seglen PO. Purification and characterization of autophagosomes from rat hepatocytes. Biochem J 1998; 335:217-24.
39. Fengsrud M, Raiborg C, Berg TO, Stromhaug PE, Ueno T, Erichsen ES, Seglen PO. Autophagosome-associated variant isoforms of cytosolic enzymes. Biochem J 2000; 352:773-81.
40. Fengsrud M, Erichsen ES, Berg TO, Raiborg C, Seglen PO. Ultrastructural characterization of the delimiting membranes of isolated autophagosomes and amphisomes by freeze-fracture electron microscopy. Eur J Cell Biol 2000; 79:871-82.
41. Wildgruber R, Harder A, Obermaier C, Boguth G, Weiss W, Fey SJ, Larsen PM, Görg A. Towards higher resolution: Two-dimensional electrophoresis of Saccharomyces cerevisiae proteins using overlapping narrow immobilized pH gradients. Electrophoresis 2000; 21:2610-6.
42. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem 1996; 68:850-8.
43. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing, EMBO J 2000; 19:5720-8.
44. Vance DE, Walkey CJ, Cui Z. Phosphatidylethanolamine N- methyltransferase from liver. Biochim Biophys Acta 1997; 1348:142-50.
45. Seglen PO. Preparation of isolated rat liver cells. Meth Cell Biol 1976; 13:29-83.
46. Berg TO, Stromhaug PE, Berg T, Seglen PO. Separation of lysosomes and autophagosomes by means of glycyl-phenylalanine-naphtylamide, a lysosome-disrupting substrate for cathepsin C. Eur J Biochem 1994; 221:595-602.
47. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
48. Samari HR, Møller MTN, Holden L, Asmyhr T, Seglen PO. Stimulation of hepatocytic AMP-activated protein kinase by okadaic acid and other autophagy-suppressive toxins. Biochem J 2005; 386:237-44.
49. 14C]lactose, to distinguish between pre-lysosomal and lysosomal steps in the autophagic pathway. Exp Cell Res 1986;166:1-14.
50. Kovács AL, Reith A, Seglen PO. Accumulation of autophagosomes after inhibition of hepatocytic protein degradation by vinblastine, leupeptin or a lysosomotropic amine. Exp Cell Res 1982; 137:191-201.
51. Kuramitsu Y, Fujimoto M, Tanaka T, Ohata J, Nakamura K. Differential expression of phosphatidylethanolamine-binding protein in rat hepatoma cell lines: Analyses of tumor necrosis factor-α-resistant cKDH-8/11 and -sensitive KDH-8/YK cells by two-dimensional gel electrophoresis. Electrophoresis 2000; 21:660-4.
52. Jones R, Hall L. A 23 kDa protein from rat sperm plasma membranes shows sequence similarity and phospholipid binding properties to a bovine brain cytosolic protein. Biochim Biophys Acta 1991; 1080:78-82.
53. Bollengier F, Foriers A, Lauwereys M, Mahler A. Further biochemical characterization of the polyneuropeptide h3 recently isolated from human brain material, and its identification in human liver. Neuropeptides 1983; 3:243-54.
54. Bernier I, Jolles P. Purification and characterization of a basic 23 kDa cytosolic protein from bovine brain. Biochim Biophys Acta 1984; 790:174-81.
55. Perry AC, Hall L, Bell AE, Jones R. Sequence analysis of a mammalian phospholipid-binding protein from testis and epididymis and its distribution between spermatozoa and extracellular secretions. Biochem J 1994; 301:235-42.
56. Hickox DM, Gibbs G, Morrison JR, Sebire K, Edgar K, Keah HH, Alter K, Loveland KL, Hearn MT, de Kretser DM, O'Bryan MK. Identification of a novel testis-specific member of the phosphatidylethanolamine binding protein family, pebp-2. Biol Reprod 2002; 67:917-27.
57. Goumon Y, Angelone T, Schoentgen F, Chasserot-Golaz S, Almas B, Fukami MM, Langley K, Weltets ID, Tota B, Aunis D, Metz-Boutigue MH. The hippocampal cholinergic neurostimulating peptide, the N-terminal fragment of the secreted phosphatidylethanolamine-binding protein, possesses a new biological activity on cardiac physiology. J Biol Chem 2004; 279:13054-464.
58. Vallee BS, Tauc P, Brochon JC, Maget-Dana R, Lelievre D, Metz-Boutigue MH, Bureaud N, Schoentgen F. Behaviour of bovine phosphatidylethanolamine- binding protein with model membranes: Evidence of affinity for negatively charged membranes. Eur J Biochem 2001;268:5831-41.
59. Schoentgen F, Jolles P. From structure to function: Possible biological roles of a new widespread protein family binding hydrophobic ligands and displaying a nucleotide binding site. FEBS Lett 1995; 369:22-6.
60. Chautard H, Jacquet M, Schoentgen F, Bureaud N, Benedetti H. Trs1p, a member of the PEBP family, inhibits the Ira2p but not the Ira1p Ras GTPase-activating protein in Saccharomyces cerevisiae. Eukaryot Cell 2004; 3:459-70.
61. Odabaei G, Chatterjee D, Jazirehi AR, Goodglick L, Yeung K, Bonavida B. Raf-1 kinase inhibitor protein: Structure, function, regulation of cell signaling, and pivotal role in apoptosis. Adv Cancer Res 2004; 91:169-200.
62. Pattingre S, Bauvy C, Codogno P. Amino acids interfere with the ERK1/2-dependent control of mactoautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells. J Biol Chem 2003; 278:16667-74.
63. MAPK activation. Biochem J 2001; 354:31-6.
64. Ruud Larsen AK, Møller MTN, Blankson H, Samari HR, Holden L, Seglen PO. Naringin-sensitive phosphorylation of plectin, a cytoskeletal crosslinking protein, in isolated rat hepatocytes. J Biol Chem 2002; 277:34826-35.
65. Kroslak T, Koch T, Kahl E, Hollt V. Human phosphatidylethanolamine- binding protein facilitates heterotrimeric G protein-dependent signaling. J Biol Chem 2001; 276:39772-8.
66. Pattingre S, Petiot A, Codogno P. Analyses of G alpha-interacting protein and activator of G-protein-signaling-3 functions in macroautophagy. Methods Enzymol 2004; 390:17-31.
67. Lorenz K, Lohse MJ, Quitterer U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 2003; 426:574-9.
68. Ichimuta Y, Kirisako T, Takao T, Satomi Y, Shimonishi Y, Ishihata N, Mizushima N, Tanida I, Kominami E, Ohsumi M, Noda T, Ohsumi Y. A ubiquitin-like system mediates protein lipidation. Nature 2000; 408:488-92.
69. Yorimitsu T, Klionsky DJ. Autophagy: Molecular machinery for self-eating. Cell Death Differ 2005; 12:1542-52.
70. Hengst U, Albrecht H, Hess D, Monard D. The phosphatidylethanolamine- binding protein is the prototype of a novel family of serine protease inhibitors. J Biol Chem 2001; 276:535-40.
71. Raxworthy MJ, Gulliver PA, Hughes PJ. The cellular location of catechol-O-methyltransferase in rat liver. Naunyn Schmiedebergs Arch Pharmacol 1982; 320:182-8.
72. Tilgmann C, Melen K, Lundstrom K, Jalanko A, Julkunen I, Kalkkinen N, Ulmanen I. Expression of recombinant soluble and membrane-bound catechol O-methyltransferase in eukaryotic cells and identification of the respective enzymes in rat brain. Eur J Biochem 1992;207:813-21.
73. Lundstrom K, Tenhunen J, Tilgmann C, Karhunen T, Panula P, Ulmanen I. Cloning, expression and structure of catechol-O-methyltransferase. Biochim Biophys Acta 1995; 1251:1-10.
74. Tilgmann C, Kalkkinen N. Purification and partial characterization of rat liver soluble catechol-O-methyltransferase. FEBS Lert 1990; 264:95-9.
75. Karhunen T, Tilgmann C, Ulmanen I, Julkunen I, Panula P. Distribution of catechol-O-methyltransferase enzyme in rat tissues. J Histochem Cytochem 1994; 42:1079-90.
76. Lautala P, Ulmanen I, Taskinen J. Molecular mechanisms controlling the rate and specificity of catechol O-methylation by human soluble catechol O-methyltransferase. Mol Pharmacol 2001;59:393-402.
77. Breuer O. Identification and quantitation of cholest-5-ene-3β, 4β-diol in rat liver and human plasma. J Lipid Res 1995; 36:2275-81.
78. Bodin K, Andersson U, Rystedt E, Ellis E, Norlin M, Pikuleva I, Eggertsen G, Bjorkhem I, Diczfalusy U. Metabolism of 4β-hydroxycholesterol in humans. J Biol Chem 2002; 277:31534-40.
79. Punnonen EL, Reunanen H, Hirsimäki P, Lounatmaa K. Filipin labelling and intramembrane particles on the membranes of early and later autophagic vacuoles in Ehrlich ascites cells. Virchows Arch B Cell Pathol 1988; 54:317-26.
80. 14C]sucrose in hepatocytes. Biochem J 1985; 232:773-80.
81. Delgado-Reyes CV, Wallig MA, Garrow TA. Immunohistochemical detection of betaine-homocysteine S-methyltransferase in human, pig, and rat liver and kidney. Arch Biochem Biophys 2001; 393:184-6.
82. Garrow TA. Purification, kinetic properties, and cDNA cloning of mammalian betaine-homocysteine methyl transferase. J Biol Chem 1996; 271:22831-8.
83. McKeever MP, Weir DG, Molloy A, Scott JM. Betaine-homocysteine methyltransferase: Organ distribution in man, pig and rat and subcellular distribution in the rat. Clin Sci (Lond) 1991;81:551-6.
84. Sandu C, Nick P, Hess D, Schiltz E, Garrow TA, Brandsch R. Association of betaine-homocysteine S-methyltransferase with microtubules. Biol Chem 2000; 381:619-22.
85. Sehayek E, Wang R, Ono JG, Zinchuk VS, Duncan EM, Shefer S, Vance DE, Ananthanarayanan M, Chait BT, Breslow JL. Localization of the PE methylation pathway and SR-BI to the canalicular membrane: Evidence for apical PC biosynthesis that may promote biliary excretion of phospholipid and cholesterol. J Lipid Res 2003; 44:1605-13.
86. Ueno T, Ishidoh K, Mineki R, Tanida I, Murayama K, Kadowaki M, Kominami E. Autolysosomal membrane-associated betaine homocysteine methyltransferase: Limited degradation fragment of a sequestered cytosolic enzyme monitoring autophagy. J Biol Chem 1999;274:15222-9.
87. Furuya N, Kanazawa T, Fujimura S, Ueno T, Kominami E, Kadowaki M. Leupeptin-induced appearance of partial fragment of betaine homocysteine methyltransferase during autophagic maturation in rat hepatocytes. J Biochem (Tokyo) 2001; 129:313-20.
88. Evans JC, Huddler DP, Jiracek J, Castro C, Millian NS, Garrow TA, Ludwig ML. Betaine-homocysteine methyltransferase: Zinc in a distorted barrel. Structure (Camb) 2002; 10:1159-71.
89. Miller CM, Szegedi SS, Garrow TA. Conformation-dependent inactivation of human betaine-homocysteine S-methyltransferase by hydrogen peroxide in vitro. Biochem J 2005; 392:3-8.
90. Park B, Oh SH, Seong JK, Paik YK. A strain-specific alteration of proteomic expression in mouse liver fructose 1,6-bisphosphatase isoforms by alcohol. Proteoinics 2004; 4:3413-21.
91. Lu SC, Mato JM. Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer. Alcohol 2005; 35:227-34.
92. Yang Z, Wensel TG. Molecular cloning and functional expression of cDNA encoding a mammalian inorganic pyrophosphatase. J Biol Chem 1992; 267:24641-7.
93. Smirnova IN, Baykov AA. Reversible inactivation of rat liver inorganic pyrophosphatase by substrate and its analogs. Arch Biochem Biophys 1991; 287:135-40.
94. Shatton JB, Shah H, Williams A, Morris HP, Weinhouse S. Activities and properties of inorganic pyrophosphate in normal tissues and hepatic tumors of the rat. Cancer Res 1981; 41:1866-72.
95. Yang Z, Wensel TG. Inorganic pyrophosphatase from bovine retinal rod outer segments. J Biol Chem 1992; 267:24634-40.
96. Terkeltaub RA. Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Physiol Cell Physiol 2001; 281:C1-C11.
97. Griffiths EJ, Halestrap AP. Pyrophosphate metabolism in the perfused heart and isolated heart mitochondria and its role in regulation of mitochondrial function by calcium. Biochem J 1993;290:489-95.
98. Smirnova IN, Kasho VN, Volk SE, Ivanov AH, Baykov AA. Rates of elementary steps catalyzed by rat liver cytosolic and mitochondrial inorganic pyrophosphatases in both directions. Arch Biochem Biophys 1995; 318:340-8.
99. Sharton JB, Williams A, Weinhouse S. Subcellular distribution of inorganic pyrophosphatase activity in various normal and neoplastic cell types. Cancer Res 1983; 43:3742-7.
100. 6-mercaptopurine riboside: Evidence for involvement of AMP-activated protein kinase. J Biol Chem 1998; 273:23758-63.
101. Carling D. The AMP-activated protein kinase cascade - A unifying system for energy control. Trends Biochem Sci 2004; 29:18-24.
102. McNally T, Helfrich RJ, Cowart M, Dorwin SA, Meuth JL, Idler KB, Klute KA, Simmer RL, Kowaluk EA, Halberr DN. Cloning and expression of the adenosine kinase gene from rat and human tissues. Biochem Biophys Res Commun 1997; 231:645-50.
103. Sakowicz M, Grden M, Pawelczyk T. Expression level of adenosine kinase in rat tissues: Lack of phosphate effect on the enzyme activity. Acta Biochim Pol 2001; 48:745-54.
104. Miller RL, Adamczyk DL, Miller WH. Adenosine kinase from rabbir liver. I. Purification by affinity chromatography and properties. J Biol Chem 1979; 254:2339-45.
105. Chang CH, Brockman RW, Bennett Jr LL. Adenosine kinase from L1210 cells: Purification and some properties of the enzyme. J Biol Chem 1980; 255:2366-71.
106. Kovacs AL, Gordon PB, Grotterod EM, Seglen PO. Inhibition of heparocytic autophagy by adenosine, adenosine analogues and AMP. Biol Chem 1998; 379:1341-7.
107. 2 and its organ distribution. Am J Physiol 1998; 274:L750-61.
108. 2 activities. J Biol Chem 2000; 275:28421-7.
109. 2 and properties of the expressed protein. J Biol Chem 1997;272:2542-50.
110. 2 and turnover of alveolar DPPC. Am J Physiol Lung Cell Mol Physiol 2001; 280:L748-54.
111. Kang SW, Baines IC, Rhee SG. Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J Biol Chem 1998; 273:6303-11.
112. Chevallet M, Wagner E, Luche S, van Dorsselaer A, Leize-Wagner E, Rabilloud T. Regeneration of peroxiredoxins during recovery after oxidative stress: Only some overoxidized peroxiredoxins can be reduced during recovery after oxidative stress. J Biol Chem 2003; 278:37146-53.
113. Pak JH, Manevich Y, Kim HS, Feinstein SI, Fisher AB. An antisense oligonucleotide to 1-cys peroxiredoxin causes lipid peroxidation and apoptosis in lung epithelial cells. J Biol Chem 2002; 277:49927-34.
114. Wang Y, Manevich Y, Feinsrein SI, Fisher AB. Adenovirus-mediated transfer of the 1-cys peroxiredoxin gene to mouse lung protects against hyperoxic injury. Am J Physiol Lung Cell Mol Physiol 2004; 286:L1188-93.
115. 2-independent peroxiredoxin VI activity in the survival of immortalized fibroblasts exposed to cytotoxic oxidative stress. FEBS Lett 2004; 557:26-32.
116. Manevich Y, Fisher AB. Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radic Biol Med 2005; 38:1422-32.
117. Corda D, Hidalgo CC, Bonazzi M, Luini A, Spano S. Molecular aspects of membrane fission in the secretory pathway. Cell Mol Life Sci 2002; 59:1819-32.
118. Ralat LA, Manevich Y, Fisher AB, Colman RF. Direct evidence for the formation of a complex between 1-cysteine peroxiredoxin and glutathione S-transferase π with activity changes in both enzymes. Biochemistry 2006; 45:360-72.
119. McMahon HT, Gallop JL. Membrane curvature and mechanisms of dynamic cell membrane remodelling. Nature 2005; 438:590-6.
120. Stead LM, Brosnan JT, Brosnan ME, Vance DE, Jacobs RL. Is it time to reevaluate methyl balance in humans? Am J Clin Nutr 2006; 83:5-10.
121. Cui Z, Vance JE, Chen MH, Voelker DR, Vance DE. Cloning and expression of a novel phosphatidylethanolamine N-methyltransferase: A specific biochemical and cytological marker for a unique membrane fraction in rat liver. J Biol Chem 1993; 268:16655-63.
122. Vance JE. Phospholipid synthesis in a membrane fraction associated with mitochondria. J Biol Chem 1990; 265:7248-56.
123. Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, Rhee SG. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α. J Biol Chem 1998; 273:6297-302.
124. Choi MH, Lee IK, Kim GW, Kim BU, Han YH, Yu DY, Park HS, Kim KY, Lee JS, Choi C, Bae YS, Lee BI, Rhee SG, Kang SW. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 2005; 435:347-53.
125. Jang HH, Lee KO, Chi YH, Jung BG, Park SK, Park JH, Lee JR, Lee SS, Moon JC, Yun JW, Choi YO, Kim WY, Kang JS, Cheong GW, Yun DJ, Rhee SG, Cho MJ, Lee SY. Two enzymes in one; two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function. Cell 2004; 117:625-35.
126. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005; 38:1543-52.
127. Wood ZA, Schroder E, Robin HJ, Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 2003; 28:32-40.
128. 2-induced cell death. J Biol Chem 2005; 280:28775-84.
129. Kim SH, Fountoulakis M, Cairns N, Lubec G. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome. J Neural Transm Suppl 2001; 223-35.
130. Kato S, Saeki Y, Aoki M, Nagai M, Ishigald A, Itoyama Y, Kato M, Asayama K, Awaya A, Hirano A, Ohama E. Histological evidence of redox system breakdown caused by superoxide dismutase 1 (SOD1) aggregation is common to SOD1-mutated motor neurons in humans and animal models. Acta Neuropathol (Berl) 2004; 107:149-58.
131. Kawai J, Shinagawa A, Shibata K, Yoshino M, Itoh M, Ishii Y, Arakawa T, Hara A, Fukunishi Y, Konno H, Adachi J, Fukuda S, Aizawa K, Izawa M, Nishi K, Kiyosawa H, Kondo S, Yamanaka I, Saito T, Okazaki Y, Gojobori T, Bono H, Kasukawa T, Saito R, Kadota K, Matsuda H, Ashburner M, Batalov S, Casavant T, Fleischmann W, Gaasterland T, Gissi C, King B, Kochiwa H, Kuehl P, Lewis S, Matsuo Y, Nikaido I, Pesole G, Quackenbush J, Schriml LM, Staubli F, Suzuki R, Tomita M, Wagner L, Washio T, Sakai K, Okido T, Furuno M, Aono H, Baldarelli R, Barsh G, Blake J, Boffelli D, Bojunga N, Carninci P, de Bonaldo MF, Brownstein MJ, Bult C, Fletcher C, Fujita M, Gariboldi M, Gustincich S, Hill D, Hofmann M, Hume DA, Kamiya M, Lee NH, Lyons P, Marchionni L, Mashima J, Mazzarelli J, Mombaerts P, Nordone P, Ring B, Ringwald M, Rodriguez I, Sakamoto N, Sasaki H, Sato K, Schonbach C, Seya T, Shibata Y, Storch KF, Suzuki H, Toyo-oka K, Wang KH, Weitz C, Whittaker C, Wilming L, Wynshaw-Boris A, Yoshida K, Hasegawa Y, Kawaji H, Kohtsukl S, Hayashizaki Y. Functional annotation of a full-length mouse cDNA collection. Narure 2001; 409:685-90.
132. Jiang J, Prasad K, Lafer EM, Sousa R. Structural basis of interdomain communication in the Hsc70 chaperone. Mol Cell 2005; 20:513-24.
133. Perez-Vargas J, Romero P, Lopez S, Arias CF. The peptide-binding and ATPase domains of recombinant hsc70 are required to interact with rotavirus and reduce its infectivity. J Virol 2006; 80:3322-31.
134. Majeski AE, Dice JF. Mechanisms of chaperone-mediated autophagy. Int J Biochem Cell Biol 2004; 36:2435-44.
135. Cuervo AM, Knecht E, Terlecky SR, Dice JF. Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation. Am J Physiol Cell Physiol 1995; 269: C1200-8.
136. Bercovich B, Stancovski I, Mayer A, Blumenfeld N, Laszlo A, Schwartz AL, Ciechanover A. Ubiquitin-dependent degradation of certain protein substrates in vitro requires the molecular chaperone Hsc70. J Biol Chem 1997; 272:9002-10.
137. Urushitani M, Kurisu J, Tateno M, Hatakeyama S, Nakayama K, Kato S, Takahashi R. CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70. J Neurochem 2004; 90:231-44.
138. Arndt V, Daniel C, Nastainczyk W, Alberti S, Hohfeld J. BAG-2 acts as an inhibitor of the chaperone-associated ubiquitin ligase CHIP. Mol Biol Cell 2005; 16:5891-900.
139. Kopito RR. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 2000; 10:524-30.
140. Meriin AB, Sherman MY. Role of molecular chaperones in neurodegenerative disorders. Int J Hyperthermia 2005; 21:403-19.
141. Ravikumar B, Duden R, Rubinszrein DC. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet 2002; 11:1107-17.
142. Taylor JP, Tanaka F, Robitschek J, Sandoval CM, Taye A, Markovic-Plese S, Fischbeck KH. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum Mol Genet 2003; 12:749-57.
143. Webb JL, Ravikumar B, Atkins J, Skepper JN, Rubinsztein DC. α-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem 2003; 278:25009-13.
144. Rideout HJ, Lang-Rollin I, Srefanis L. Involvement of macroautophagy in the dissolution of neuronal inclusions. Int J Biochem Cell Biol 2004; 36:2551-62.
145. Iwata A, Christianson JC, Bucci M, Ellerby LM, Nukina N, Forno LS, Kopito RR. Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation. Proc Natl Acad Sci USA 2005; 102:13135-40.
146. Lee YC, Lai YK. Integrity of intermediate filaments is associated with the development of acquired thermotolerance in 9L rat brain tumor cells. J Cell Biochem 1995; 57:150-62.
147. Haraguchi CM, Mabuchi T, Hirata S, Shoda T, Hoshi K, Akasaki K, Yokota S. Chromatoid bodies: Aggresome-like characteristics and degradation sites for organelles of spermiogenic cells. J Histochem Cytochem 2005; 53:455-65.
148. Simonsen A, Birkeland HC, Gillooly DJ, Mizushima N, Kuma A, Yoshimori T, Slagsvold T, Brech A, Stenmark H. Alfy, a novel FYVE-domain-containing protein associated with protein granules and autophagic membranes. J Cell Sci 2004; 117:18-51.
149. Bjørkøy G, Lamark T, Brech A, Outzen H, Perander M, Øvervatn A, Stenmark H, Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 2005; 171:603-614.
150. Zhao R, Houry WA. Hsp90: A chaperone for protein folding and gene regulation. Biochem Cell Biol 2005; 83:703-10.
151. Kleizen B, Braakman I. Protein folding and quality control in the endoplasmic reticulum. Curr Opin Cell Biol 2004; 16:343-9.
152. Blankson H, Holen I, Seglen PO. Disruption of thecytokeratin cytoskeleton and inhibition of hepatocytic autophagy by okadaic acid. Exp Cell Res 1995; 218:522-30.
153. Ekdahl KN. Rat liver fructose- 1,6-bisphosphatase: Identification of serine 338 as a third major phosphorylation site for cyclic AMP-dependent protein kinase and activity changes associated with mulrisite phosphorylation in vitro. J Biol Chem 1987; 262:16699-703.
154. Liu F, Fromm HJ. Kinetic studies on the mechanism and regulation of rabbit liver fructose-1,6-bisphosphatase. J Biol Chem 1990; 265:7401-6.
155. Yuan WP, Tuttle DL, Shi YJ, Ralph GS, Dunn WA. Glucose-induced microautophagy in Pichia pastoris requires the α-subunit of phosphofructokinase. J Cell Sci 1997; 110:1935-45.
156. Hung GC, Brown CR, Wolfe AB, Liu J, Chiang HL. Degradation of the gluconeogenic enzymes fructose-1,6-bisphosphatase and malate dehydrogenase is mediated by distinct proteolytic pathways and signaling events. J Biol Chem 2004; 279:49138-50.
157. Schüle T, Rose M, Entian KD, Thumm M, Wolf DH. Ubc8p functions in catabolite degradation of fructose-1, 6-bisphosphatase in yeast. EMBO J 2000; 19:2161-7.
158. Pancholi V. Multifunctional α-enolase: Its role in diseases. Cell Mol Life Sci 2001; 58:902-20.
159. Sirover MA. New insights into an old protein: The functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 1999; 1432:159-84.
160. Glaser PE, Gross RW. Rapid plasmenylethanolamine-selective fusion of membrane bilayers catalyzed by an isoform of glyceraldehyde-3-phosphate dehydrogenase: Discrimination between glycolytic and fusogenic roles of individual isoforms. Biochemistry 1995; 34:12193-203.
161. Cuervo AM, Dice JF. Unique properties of lamp2a compared to other lamp2 isoforms. J Cell Sci 2000; 113:4441-50.
162. Lunde Sneve M, Øverbye A, Fengsrud M, Seglen PO. Comigration of two autophagosome-associated dehydrogenases on two-dimensional polyacrylamide gels. Autophagy 2005; 1:157-62.
163. Vandercammen A, van Schaftingen E. The mechanism by which rat liver glucokinase is inhibited by the regulatory protein. Eur J Biochem 1990; 191:483-9.
164. Detheux M, Vandekerckhove J, van Schaftingen E. Cloning and sequencing of rat liver cDNAs encoding the regulatory protein of glucokinase. FEBS Lett 1993; 321:111-5.
165. Toyoda Y, Miwa I, Satake S, Anai M, Oka Y. Nuclear location of the regulatory protein of glucokinase in rat liver and translocation of the regulator to the cytoplasm in response to high glucose. Biochem Biophys Res Commun 1995; 215:467-73.
166. Farrelly D, Brown KS, Tieman A, Ren J, Lira SA, Hagan D, Gregg R, Mookhtiar KA, Hariharan N. Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: A sequestration mechanism in metabolic regulation. Proc Natl Acad Sci USA 1999; 96:14511-6.
167. Mukhtar M, Stubbs M, Agius L. Evidence for glucose and sorbitol-induced nuclear export of glucokinase regulatory protein in hepatocytes. FEBS Lett 1999; 462:453-8.
168. Arden C, Baltrusch S, Agius L. Glucokinase regulatory protein is associated with mitochondria in hepatocytes. FEBS Lett 2006; 580:2065-70.
169. Mattow J, Demuth I, Haeselbarth G, Jungblut PR, Klose J. Selenium-binding protein 2, the major hepatic target for acetaminophen, shows sex differences in protein abundance. Electrophoresis 2006; 27:1683-91.
170. Lanfear J, Fleming J, Walker M, Harrison P. Different patterns of regulation of the genes encoding the closely related 56 kDa selenium- and acetaminophen-binding proteins in normal tissues and during carcinogenesis. Carcinogenesis 1993; 14:335-40.
171. Giometti CS, Liang X, Tollaksen SL, Wall DB, Lubman DM, Subbarao V, Rao MS. Mouse liver selenium-binding protein decreased in abundance by peroxisome proliferators. Electrophoresis 2000; 21:2162-9.
172. Manautou JE, Khairallah EA, Cohen SD. Evidence for common binding of acetaminophen and bromobenzene to the 58-kDa acetaminophen-binding protein. J Toxicol Environ Health 1995; 46:263-9.
173. Pumford NR, Martin BM, Hinson JA. A metabolite of acetaminophen covalently binds to the 56 kDa selenium binding protein. Biochem Biophys Res Commun 1992; 182:1348-55.
174. Ishii Y, Hatsumura M, Ishida T, Ariyoshi N, Oguri K. Significant induction of a 54-kDa protein in rat liver with homologous alignment to mouse selenium binding protein by a coplanar polychlorinated biphenyl, 3,4,5,3′,4′-pentachlorobiphenyl and 3-methylcholanthrene. Toxicol Lett 1996; 87:1-9.
175. Behne D, Kyriakopoulos A. Mammalian selenium-containing proteins. Annu Rev Nutr 2001;21:453-73.
176. Sinha R, Bansal MP, Ganther H, Medina D. Significance of selenium-labeled proteins for selenium's chemopreventive functions. Carcinogenesis 1993; 14:1895-900.
177. Cohen SD, Pumford NR, Khairallah EA, Boekelheide K, Pohl LR, Amouzadeh HR, Hinson JA. Selective protein covalent binding and target organ toxicity. Toxicol Appl Pharmacol 1997;143:1-12.
178. Bruno MK, Cohen SD, Khairallah EA. Antidotal effectiveness of N-acetylcysteine in reversing acetaminophen-induced hepatotoxicity: Enhancement of the proteolysis of arylated proteins. Biochem Pharmacol 1988; 37:4319-25.
179. Porat A, Sagiv Y, Elazar Z. A 56-kDa selenium-binding protein participates in intra-Golgi protein transport. J Biol Chem 2000; 275:14457-65.
180. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51-88.
181. Chapman E, Best MD, Hanson SR, Wong CH. Sulfotransferases: Structure, mechanism, biological activity, inhibition, and synthetic utility. Angew Chem Int Ed Engl 2004; 43:3526-48.
182. Penning TM, Jin Y, Heredia W, Lewis M. Structure-function relationships in 3α-hydroxysteroid dehydrogenases: A comparison of the rat and human isoforms. J Steroid Biochem Mol Biol 2003; 85:247-55.
183. 4-3-ketosteroid 5β-reductase. Hepatology 1996; 23:115-22.
184. 4-3-ketosteroid 5β-reductase of rat liver. FEBS Lett 1991; 283:215-8.
185. Matsunaga T, Shintani S, Hara A. Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab Pharmacokinet 2006; 21:1-18.
186. Palackal NT, Burczynski ME, Harvey RG, Penning TM. The ubiquitous aldehyde reductase (AKR1A1) oxidizes proximate carcinogen trans- dihydrodiols to o-quinones: Potential role in polycyclic aromatic hydrocarbon activation. Biochemistry 2001; 40:10901-10.
187. Rodrigo L, Gil F, Hernandez AF, Marina A, Vazquez J, Pla A. Purification and characterization of paraoxon hydrolase from rat liver. Biochem J 1997; 321:595-601.
188. van Himbergen TM, van Tits LJ, Roest M, Stalenhoef AF. The story of PON1: How an organophosphate-hydrolysing enzyme is becoming a player in cardiovascular medicine. Neth J Med 2006; 64:34-8.
189. Gil F, Pla A, Gonzalvo MC, Hernandez AF, Villanueva E. Rat liver paraoxonase: Subcellular distribution and characterization. Chem Biol Interact 1993; 87:149-54.
190. Trudel K, Sinnett D, James RW, Delvin E, Amre D, Seidman E, Levy E. Iron-ascorbic acid-induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: Comparison between humans and rats. J Cell Biochem 2005; 96:404-11.
191. Robbi M, Beaufay H, Octave JN. Nucleotide sequence of cDNA coding for rat liver pi 6.1 esterase (ES-10), a carboxylesterase located in the lumen of the endoplasmic reticulum. Biochem J 1990;269:451-8.
192. Liederer BM, Borchardt RT. Enzymes involved in the bioconversion of ester-based prodrugs. J Pharm Sci 2006; 95:1177-95.
193. Satoh T, Hosokawa M. The mammalian carboxylesterases: From molecules to functions. Annu Rev Pharmacol Toxicol 1998; 38:257-88.
194. Ghosh S, Mallonee DH, Hylemon PB, Grogan WM. Molecular cloning and expression of rat hepatic neutral cholesteryl ester hydrolase. Biochim Biophys Acta 1995; 1259:305-12.
195. Furuno K, Ishikawa T, Akasaki K, Lee S, Nishimura Y, Tsuji H, Himeno M, Kato K. Immunocytochemical study of the surrounding envelope of autophagic vacuoles in cultured rat hepatocytes. Exp Cell Res 1990; 189:261-8.
196. Zhang Y, Colabroy KL, Begley TP, Ealick SE. Structural studies on 3-hydroxyanthranilate-3,4-dioxygenase: The catalytic mechanism of a complex oxidation involved in NAD biosynthesis. Biochemistry 2005; 44:7632-43.
197. Ragazzi E, Costa CV, Caparrotta L, Biasiolo M, Bertazzo A, Allegri G. Enzyme activities along the tryptophan-nicotinic acid pathway in alloxan diabetic rabbits. Biochim Biophys Acta 2002; 1571:9-17.
198. Schwarcz R, Okuno E, White RJ, Bird ED, Whetsell Jr WO. 3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims. Proc Natl Acad Sci USA 1988; 85:4079-81.
199. Crabb DW, Edenberg HJ. Complete amino acid sequence of rat liver alcohol dehydrogenase deduced from the cDNA sequence. Gene 1986; 48:287-91.
200. Crabb DW, Matsumoto M, Chang D, You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc 2004; 63:49-63.
201. Anderson RC, Majak W, Rassmussen MA, Callaway TR, Beier RC, Nisbet DJ, Allison MJ. Toxicity and metabolism of the conjugates of 3-nitropropanol and 3-nitropropionic acid in forages poisonous to livestock. J Agric Food Chem 2005; 53:2344-50.
202. Lieber CS. Alcoholic fatty liver: Its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004; 34:9-19.
203. Umulis DM, Gurmen NM, Singh P, Fogler HS. A physiologically based model for ethanol and acetaldehyde metabolism in human beings. Alcohol 2005; 35:3-12.
204. Poschl G, Stickel F, Wang XD, Seitz HK. Alcohol and cancer: Genetic and nutritional aspects. Proc Nutr Soc 2004; 63:65-71.
205. Lieber CS. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab Rev 2004; 36:511-29.
206. Karlsson C, Jornvall H, Hoog JO. Sorbitol dehydrogenase: cDNA coding for the rat enzyme: Variations within the alcohol dehydrogenase family independent of quaternary structure and metal content. Eur J Biochem 1991; 198:761-5.
207. Hoshi A, Takahashi M, Fujii J, Myint T, Kaneto H, Suzuki K, Yamasaki Y, Kamada T, Taniguchi N. Glycation and inactivation of sorbitol dehydrogenase in normal and diabetic rats. Biochem J 1996; 318:119-23.
208. El Kabbani O, Darmanin C, Chung RP. Sorbitol dehydrogenase: Structure, function and ligand design. Curr Med Chem 2004; 11:465-76.
209. Tu LQ, Chen YY, Wright PF, Rix CJ, Bolton-Grob R, Ahokas JT. Characterization of the fluoroacetate detoxication enzymes of rat liver cytosol. Xenobiotica 2005; 35:989-1002.
210. Liou JY, Dutschman GE, Lam W, Jiang Z, Cheng YC. Characterization of human UMP/CMP kinase and its phosphorylation of D- and L-form deoxycytidine analogue monophosphates. Cancer Res 2002; 62:1624-31.
211. Van Rompay AR, Johansson M, Karlsson A. Phosphorylation of deoxycytidine analog monophosphates by UMP-CMP kinase: Molecular characterization of the human enzyme. Mol Pharmacol 1999; 56:562-9.
212. Segura-Pena D, Sekulic N, On S, Konrad M, Lavie A. Substrate-induced conformational changes in human UMP/CMP kinase. J Biol Chem 2004; 279:33882-9.
213. Gandhi V, Ayres M, Halgren RG, Krett NL, Newman RA, Rosen ST. 8-chloro-cAMP and 8-chloro-adenosine act by the same mechanism in multiple myeloma cells. Cancer Res 2001;61:5474-9.
214. Harki DA, Graci JD, Korneeva VS, Ghosh SK, Hong Z, Cameron CE, Peterson BR. Synthesis and antiviral evaluation of a mutagenic and non-hydrogen bonding ribonucleoside analogue: 1-β-D-Ribofuranosyl-3-nitropytrole. Biochemistry 2002; 41:9026-33.
215. Yamaguchi M. Role of regucalcin in maintaining cell homeostasis and function (review). Int J Mol Med 2005; 15:371-89.
216. Feng D, Kondo Y, Ishigami A, Kuramoto M, Machida T, Maruyama N. Senescence marker protein-30 as a novel antiaging molecule. Ann N Y Acad Sci 2004; 1019:360-4.
217. Shimokawa N, Yamaguchi M. Molecular cloning and sequencing of the cDNA coding for a calcium-binding protein regucalcin from rat liver. FEBS Lett 1993; 327:251-5.
218. Fujita T, Shirasawa T, Uchida K, Maruyama N. Isolation of cDNA clone encoding rat senescence marker protein-30 (SMP30) and its tissue distribution. Biochim Biophys Acta 1992; 1132:297-305.
219. Fujita T. Senescence marker protein-30 (SMP30): Structure and biological function. Biochem Biophys Res Commun 1999; 254:1-4.
220. Takahashi H, Yamaguchi M. Role of regucalcin as an activator of Ca(2+)-ATPase activity in rat liver microsomes. J Cell Biochem 1999; 74:663-9.
221. Gordon PB, Holen I, Fosse M, Røtnes S, Seglen PO. Dependence of hepatocytic autophagy on intracellularly sequestered calcium. J Biol Chem 1993; 268:26107-12.
222. Fukaya Y, Yamaguchi M. Regucalcin increases superoxide dismutase activity in rat liver cytosol. Biol Pharm Bull 2004; 27:1444-6.
223. Yamaguchi M, Nishina N. Characterization of regucalcin effect on proteolytic activity in rat liver cytosol: Relation to cysteinyl-proteases. Mol Cell Biochem 1995; 148:67-72.
224. Son TG, Zou Y, Jung KJ, Yu BP, Ishigami A, Maruyama N, Lee J. SMP30 deficiency causes increased oxidative stress in brain. Mech Ageing Dev 2006; 127:451-7.
225. Sato T, Seyama K, Sato Y, Mori H, Souma S, Aldyoshi T, Kodama Y, Mori T, Goto S, Takahashi K, Fukuchi Y, Maruyama N, Ishigami A. Senescence marker protein-30 protects mice lungs from oxidative stress, aging and smoking. Am J Respir Crit Care Med 2006; 174:530-7.
226. Kondo Y, Inai Y, Sato Y, Handa S, Kubo S, Shimokado K, Goto S, Nishikimi M, Maruyama N, Ishigami A. Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc Natl Acad Sci USA 2006; 103:5723-8.
227. Kondo Y, Ishigami A, Kubo S, Handa S, Gomi K, Hirokawa K, Kajiyama N, Chiba T, Shimokado K, Maruyama N. Senescence marker protein-30 is a unique enzyme that hydrolyzes diisopropyl phosphorofluoridate in the liver. FEBS Lett 2004; 570:57-62.
228. Tomsig JL, Creutz CE. Biochemical characterization of copine: A ubiquitous Ca2+-dependent, phospholipid-binding protein. Biochemistry 2000; 39:16163-16175.
229. Tomsig JL, Creutz CE. Copines: A ubiquitous family of Ca(2+)-dependent phospholipid-binding proteins. Cell Mol Life Sci 2002; 59:1467-77.
230. Tomsig JL, Snyder SL, Creutz CE. Idenrification of targets for calcium signaling through the copine family of proteins: Characterization of a coiled-coil copine-binding motif. J Biol Chem 2003; 278:10048-54.
231. Tomsig JL, Sohma H, Creutz CE, Calcium-dependent regulation of tumour necrosis factor-α receptor signalling by copine. Biochem J 2004; 378:3-94.
232. Yang S, Yang H, Grisafi P, Sanchatjate S, Fink GR, Sun Q, Hua J. The BON/CPN gene family represses cell dearh and promotes cell growth in Arabidopsis. Plant J 2006; 45:166-79.
233. Ramsey H, Zhang DE, Richkind K, Burcoglu-O'Ral A, Hromas R. Fusion of AML1/Runx1 to copine VIII, a novel member of the copine family, in an aggressive acute myelogenous leukemia with t(12;21) translocation. Leukemia 2003; 17:1665-6.
234. Caudell EG, Caudell JJ, Tang CH, Yu TK, Frederick MJ, Grimm EA. Characterization of human copine III as a phosphoprotein with associated kinase activity. Biochemistry 2000; 39:13034-43.
235. Darner CK, Bayeva M, Hahn ES, Rivera J, Socec CI. Copine A, a calcium-dependent membrane-binding protein, transiently localizes to the plasma membrane and intracellular vacuoles in Dictyostelium. BMC Cell Biol 2005; 6:46.
236. Raisanen SR, Lehenkari P, Tasanen M, Rahkila P, Harkonen PL, Vaananen HK. Carbonic anhydrase III protects cells from hydrogen peroxide-induced apoptosis. FASEB J 1999; 13:513-22.
237. Zimmerman UJ, Wang P, Zhang X, Bogdanovich S, Forster R. Anti-oxidative response of carbonic anhydrase III in skeletal muscle. IUBMB Life 2004; 56:343-347.
238. Saheki T, Sase M, Nakano K, Azuma F, Katsunuma T. Some properties of argininosuccinate synthetase purified from human liver and a comparison wirh the rat liver enzyme. J Biochem (Tokyo) 1983; 93:1531-7.
239. Satoh M, Iwahori T, Sugawara N, Yamazaki M. Liver argininosuccinate synthase binds to bacterial lipopolysaccharides and lipid A and inactivates their biological activiries. J Endotoxin Res 2006; 12:21-38.
240. Levine B. Eating oneself and uninvited guests: Autophagy-related pathways in cellular defense. Cell 2005; 120:159-62.
241. Amer AO, Swanson MS. Autophagy is an immediate macrophage response to Legionella pneumophila. Cell Microbiol 2005; 7:765-78.
242. Nakagawa I, Amano A, Mizushima N, Yamamoto A, Yamaguchi H, Kamimoto T, Nara A, Funao J, Nakata M, Tsuda K, Hamada S, Yoshimori T. Autophagy defends cells against invading group A Streptococcus. Science 2004; 306:1037-40.
243. Ash DE. Structure and function of arginases. J Nutr 2004; 134:2760S-4S.